Bond Teva Pharma Industries 7.875% ( US88167AAS06 ) in USD
| Issuer | Teva Pharma Industries |
| Market price | |
| Country | Israel
|
| ISIN code |
US88167AAS06 ( in USD )
|
| Interest rate | 7.875% per year ( payment 2 times a year) |
| Maturity | 15/09/2029 |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 200 000 USD |
| Total amount | 600 000 000 USD |
| Cusip | 88167AAS0 |
| Standard & Poor's ( S&P ) rating | BB ( Non-investment grade speculative ) |
| Moody's rating | Ba1 ( Non-investment grade speculative ) |
| Next Coupon | 15/03/2026 ( In 111 days ) |
| Detailed description |
Teva Pharmaceutical Industries is a global pharmaceutical company specializing in generic and specialty medications, with a focus on central nervous system disorders, respiratory diseases, oncology, and women's health. The Bond issued by Teva Pharma Industries ( Israel ) , in USD, with the ISIN code US88167AAS06, pays a coupon of 7.875% per year. The coupons are paid 2 times per year and the Bond maturity is 15/09/2029 The Bond issued by Teva Pharma Industries ( Israel ) , in USD, with the ISIN code US88167AAS06, was rated Ba1 ( Non-investment grade speculative ) by Moody's credit rating agency. The Bond issued by Teva Pharma Industries ( Israel ) , in USD, with the ISIN code US88167AAS06, was rated BB ( Non-investment grade speculative ) by Standard & Poor's ( S&P ) credit rating agency. |
Français
Italiano
Israel